FDA Approves Reduced Drinking Endpoints for Alcohol Trials: A New Road for Alcohol Treatment?
European Addiction Research · 01.06.2026 · 32 (2) · 69-71
DOI: 10.1159/000552370 ↗Kurz gefasst
Editorial in der Zeitschrift European Addiction Research, online erschienen am 01.06.2026. Verfasst von Jørgen G Bramness und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section for Clinical Addiction Research, Oslo University Hospital, Oslo, Norway, jorgen.bramness@ous-hf.no. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section for Clinical Addiction Research, Oslo University Hospital, Oslo, Norway, jorgen.bramness@ous-hf.no.
- Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway, jorgen.bramness@ous-hf.no.
- Research Center for Substance Use Disorder and Mental Illness, Hamar, Norway, jorgen.bramness@ous-hf.no.
- Antwerp University (UA, CAPRI), Antwerp, Belgium.
- Psychiatric Center Multiversum, Boechout, Belgium.
Zitieren
APA
Bramness, J. G., & Dom, G. (2026). FDA Approves Reduced Drinking Endpoints for Alcohol Trials: A New Road for Alcohol Treatment?. European Addiction Research, 32(2), 69-71. https://doi.org/10.1159/000552370
Vancouver
Bramness JG, Dom G. FDA Approves Reduced Drinking Endpoints for Alcohol Trials: A New Road for Alcohol Treatment?. European Addiction Research. 2026;32(2):69-71. doi:10.1159/000552370
BibTeX
@article{Bramness2026,
author = {Bramness, Jørgen G and Dom, Geert},
title = {FDA Approves Reduced Drinking Endpoints for Alcohol Trials: A New Road for Alcohol Treatment?},
journal = {European Addiction Research},
year = {2026},
volume = {32},
number = {2},
pages = {69--71},
doi = {10.1159/000552370}
}
EUVIMED